The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma

[1]  M. Beckmann,et al.  Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses , 2016, Cell.

[2]  Trevor J Pugh,et al.  DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts , 2015, Cell.

[3]  M. Beckmann,et al.  Abstract B32: Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses , 2016 .

[4]  P. Wei,et al.  BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs , 2015, Clinical Cancer Research.

[5]  M. Levy,et al.  Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma , 2014, Oncogene.

[6]  David T. W. Jones,et al.  Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing , 2014, Nature.

[7]  David T. W. Jones,et al.  Transitioning from genotypes to epigenotypes: Why the time has come for medulloblastoma epigenomics , 2014, Neuroscience.

[8]  Roland Eils,et al.  Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. , 2014, Cancer cell.

[9]  C. Scrideli,et al.  Zebularine induces chemosensitization to methotrexate and efficiently decreases AhR gene methylation in childhood acute lymphoblastic leukemia cells , 2014, Anti-cancer drugs.

[10]  Pei-Ming Yang,et al.  Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress , 2013, Scientific Reports.

[11]  M. Remke,et al.  Medulloblastoma molecular dissection: the way toward targeted therapy , 2013, Current opinion in oncology.

[12]  L. Ramalho,et al.  Spindle assembly checkpoint gene expression in childhood adrenocortical tumors (ACT): Overexpression of Aurora kinases A and B is associated with a poor prognosis , 2013, Pediatric blood & cancer.

[13]  S. Yip,et al.  Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children. , 2013, Cancer research.

[14]  W. Park,et al.  Zebularine-induced apoptosis in Calu-6 lung cancer cells is influenced by ROS and GSH level changes , 2013, Tumor Biology.

[15]  A. Tanoue,et al.  DNA Methyltransferase Inhibitor Zebularine Inhibits Human Hepatic Carcinoma Cells Proliferation and Induces Apoptosis , 2013, PloS one.

[16]  Paul A. Northcott,et al.  DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies , 2013, Acta Neuropathologica.

[17]  W. Zhou,et al.  The DNA methyltransferase inhibitor zebularine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo. , 2013, Biochemical and biophysical research communications.

[18]  Scott L. Pomeroy,et al.  Medulloblastomics: the end of the beginning , 2012, Nature Reviews Cancer.

[19]  M. Mehta,et al.  Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  M. Dawson,et al.  Cancer Epigenetics: From Mechanism to Therapy , 2012, Cell.

[21]  W. Park,et al.  Zebularine inhibits the growth of HeLa cervical cancer cells via cell cycle arrest and caspase-dependent apoptosis , 2012, Molecular Biology Reports.

[22]  W. Matsui,et al.  Hedgehog pathway as a drug target: Smoothened inhibitors in development , 2012, OncoTargets and therapy.

[23]  Min Chen,et al.  DNA Methyltransferase Inhibitor, Zebularine, Delays Tumor Growth and Induces Apoptosis in a Genetically Engineered Mouse Model of Breast Cancer , 2011, Molecular Cancer Therapeutics.

[24]  Scott L. Pomeroy,et al.  Molecular subgroups of medulloblastoma: the current consensus , 2011, Acta Neuropathologica.

[25]  P. Neilsen,et al.  The Application of Delivery Systems for DNA Methyltransferase Inhibitors , 2011, BioDrugs.

[26]  Minshan Chen,et al.  Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma , 2011, International journal of cancer.

[27]  G. Kolios,et al.  Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells. , 2011, World journal of gastroenterology.

[28]  J. Rey,et al.  Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, Plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma , 2010, BMC Cancer.

[29]  Michele D. Sobolewski,et al.  Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells , 2010, Breast Cancer Research and Treatment.

[30]  J. Ravanat,et al.  DNA-dependent protein kinase (DNA-PK)-deficient human glioblastoma cells are preferentially sensitized by Zebularine. , 2010, Carcinogenesis.

[31]  C. Rudin,et al.  Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma , 2009, Science.

[32]  M. Katoh,et al.  Integrative genomic analyses on GLI1: positive regulation of GLI1 by Hedgehog-GLI, TGFbeta-Smads, and RTK-PI3K-AKT signals, and negative regulation of GLI1 by Notch-CSL-HES/HEY, and GPCR-Gs-PKA signals. , 2009, International journal of oncology.

[33]  L. Medeiros,et al.  Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. , 2009, Cancer research.

[34]  T. Deng,et al.  Possible involvement of activation of P53/P21 and demethylation of RUNX 3 in the cytotoxicity against Lovo cells induced by 5-Aza-2'-deoxycytidine. , 2009, Life sciences.

[35]  C. Dullin,et al.  Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice. , 2009, Cancer research.

[36]  P. Fisher,et al.  Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN) , 2008, Proceedings of the National Academy of Sciences.

[37]  D. Altieri.  New wirings in the survivin networks , 2008, Oncogene.

[38]  A. Aboussekhra,et al.  Vincristine and lomustine induce apoptosis and p21WAF1 up-regulation in medulloblastoma and normal human epithelial and fibroblast cells , 2008, Journal of Neuro-Oncology.

[39]  S. Echigo,et al.  Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma. , 2007, International journal of oncology.

[40]  L. Salford,et al.  Low dose Zebularine treatment enhances immunogenicity of tumor cells. , 2007, Cancer letters.

[41]  T. McDonnell,et al.  The sonic hedgehog signaling network in development and neoplasia. , 2007, Advances in anatomic pathology.

[42]  B. Scheithauer,et al.  The 2007 WHO Classification of Tumours of the Central Nervous System , 2007, Acta Neuropathologica.

[43]  Ting-Chao Chou,et al.  Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.

[44]  J. Fangusaro,et al.  Survivin: An inhibitor of apoptosis in pediatric cancer , 2006, Pediatric blood & cancer.

[45]  A. Cör,et al.  Survivin is a negative prognostic marker in medulloblastoma , 2005, Neuropathology and applied neurobiology.

[46]  V. Marquez,et al.  Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells. , 2005, Biochemical Pharmacology.

[47]  Gangning Liang,et al.  Preferential response of cancer cells to zebularine. , 2004, Cancer cell.

[48]  Wei Ye,et al.  Inhibition of DNA methylation and reactivation of silenced genes by zebularine. , 2003, Journal of the National Cancer Institute.

[49]  Michael D. Cole,et al.  Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors , 2003, Development.

[50]  S. Cory,et al.  The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.

[51]  James M. Olson,et al.  Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade , 2002, Science.

[52]  Xin Lu,et al.  Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.

[53]  P. Ingham,et al.  Hedgehog signaling in animal development: paradigms and principles. , 2001, Genes & development.

[54]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[55]  D. Rowitch,et al.  Sonic hedgehog Promotes G1 Cyclin Expression and Sustained Cell Cycle Progression in Mammalian Neuronal Precursors , 2000, Molecular and Cellular Biology.

[56]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[57]  U. Strausfeld,et al.  Cyclin a is required for the onset of DNA replication in mammalian fibroblasts , 1991, Cell.

[58]  J. Uhm.  Medulloblastoma Comprises Four Distinct Molecular Variants , 2011 .

[59]  J. Haveman,et al.  Clonogenic assay of cells in vitro , 2006, Nature Protocols.

[60]  I. McNeish,et al.  Survivin: a protein with dual roles in mitosis and apoptosis. , 2005, International review of cytology.

[61]  David A Jones,et al.  Activation of the p 53 DNA Damage Response Pathway after Inhibition of DNA Methyltransferase by 5-Aza-2 9-deoxycytidine , 2001 .